Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition

Arachidonic acid (AA) is a main component of cell membrane lipids. AA is mainly metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP450). Esterified AA is hydrolysed by phospholipase A 2 into a free form that is further metabolized by COX, LOX and CYP450 to...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 15; p. 1365802
Main Authors Li, Xiao-Jun, Suo, Ping, Wang, Yan-Ni, Zou, Liang, Nie, Xiao-Li, Zhao, Ying-Yong, Miao, Hua
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 2024
Subjects
acute kidney injury
arachidonic acid
chronic kidney disease
inflammation
oxidative stress
renal cell carcinoma
arachidonic acid
chronic kidney disease
renal cell carcinoma
acute kidney injury
inflammation
oxidative stress
Online AccessGet full text
ISSN1663-9812
1663-9812
DOI10.3389/fphar.2024.1365802

Cover

Abstract Arachidonic acid (AA) is a main component of cell membrane lipids. AA is mainly metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP450). Esterified AA is hydrolysed by phospholipase A 2 into a free form that is further metabolized by COX, LOX and CYP450 to a wide range of bioactive mediators, including prostaglandins, lipoxins, thromboxanes, leukotrienes, hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. Increased mitochondrial oxidative stress is considered to be a central mechanism in the pathophysiology of the kidney. Along with increased oxidative stress, apoptosis, inflammation and tissue fibrosis drive the progressive loss of kidney function, affecting the glomerular filtration barrier and the tubulointerstitium. Recent studies have shown that AA and its active derivative eicosanoids play important roles in the regulation of physiological kidney function and the pathogenesis of kidney disease. These factors are potentially novel biomarkers, especially in the context of their involvement in inflammatory processes and oxidative stress. In this review, we introduce the three main metabolic pathways of AA and discuss the molecular mechanisms by which these pathways affect the progression of acute kidney injury (AKI), diabetic nephropathy (DN) and renal cell carcinoma (RCC). This review may provide new therapeutic targets for the identification of AKI to CKD continuum.
AbstractList Arachidonic acid (AA) is a main component of cell membrane lipids. AA is mainly metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP450). Esterified AA is hydrolysed by phospholipase A2 into a free form that is further metabolized by COX, LOX and CYP450 to a wide range of bioactive mediators, including prostaglandins, lipoxins, thromboxanes, leukotrienes, hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. Increased mitochondrial oxidative stress is considered to be a central mechanism in the pathophysiology of the kidney. Along with increased oxidative stress, apoptosis, inflammation and tissue fibrosis drive the progressive loss of kidney function, affecting the glomerular filtration barrier and the tubulointerstitium. Recent studies have shown that AA and its active derivative eicosanoids play important roles in the regulation of physiological kidney function and the pathogenesis of kidney disease. These factors are potentially novel biomarkers, especially in the context of their involvement in inflammatory processes and oxidative stress. In this review, we introduce the three main metabolic pathways of AA and discuss the molecular mechanisms by which these pathways affect the progression of acute kidney injury (AKI), diabetic nephropathy (DN) and renal cell carcinoma (RCC). This review may provide new therapeutic targets for the identification of AKI to CKD continuum.Arachidonic acid (AA) is a main component of cell membrane lipids. AA is mainly metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP450). Esterified AA is hydrolysed by phospholipase A2 into a free form that is further metabolized by COX, LOX and CYP450 to a wide range of bioactive mediators, including prostaglandins, lipoxins, thromboxanes, leukotrienes, hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. Increased mitochondrial oxidative stress is considered to be a central mechanism in the pathophysiology of the kidney. Along with increased oxidative stress, apoptosis, inflammation and tissue fibrosis drive the progressive loss of kidney function, affecting the glomerular filtration barrier and the tubulointerstitium. Recent studies have shown that AA and its active derivative eicosanoids play important roles in the regulation of physiological kidney function and the pathogenesis of kidney disease. These factors are potentially novel biomarkers, especially in the context of their involvement in inflammatory processes and oxidative stress. In this review, we introduce the three main metabolic pathways of AA and discuss the molecular mechanisms by which these pathways affect the progression of acute kidney injury (AKI), diabetic nephropathy (DN) and renal cell carcinoma (RCC). This review may provide new therapeutic targets for the identification of AKI to CKD continuum.
Arachidonic acid (AA) is a main component of cell membrane lipids. AA is mainly metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP450). Esterified AA is hydrolysed by phospholipase A 2 into a free form that is further metabolized by COX, LOX and CYP450 to a wide range of bioactive mediators, including prostaglandins, lipoxins, thromboxanes, leukotrienes, hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. Increased mitochondrial oxidative stress is considered to be a central mechanism in the pathophysiology of the kidney. Along with increased oxidative stress, apoptosis, inflammation and tissue fibrosis drive the progressive loss of kidney function, affecting the glomerular filtration barrier and the tubulointerstitium. Recent studies have shown that AA and its active derivative eicosanoids play important roles in the regulation of physiological kidney function and the pathogenesis of kidney disease. These factors are potentially novel biomarkers, especially in the context of their involvement in inflammatory processes and oxidative stress. In this review, we introduce the three main metabolic pathways of AA and discuss the molecular mechanisms by which these pathways affect the progression of acute kidney injury (AKI), diabetic nephropathy (DN) and renal cell carcinoma (RCC). This review may provide new therapeutic targets for the identification of AKI to CKD continuum.
Arachidonic acid (AA) is a main component of cell membrane lipids. AA is mainly metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP450). Esterified AA is hydrolysed by phospholipase A into a free form that is further metabolized by COX, LOX and CYP450 to a wide range of bioactive mediators, including prostaglandins, lipoxins, thromboxanes, leukotrienes, hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. Increased mitochondrial oxidative stress is considered to be a central mechanism in the pathophysiology of the kidney. Along with increased oxidative stress, apoptosis, inflammation and tissue fibrosis drive the progressive loss of kidney function, affecting the glomerular filtration barrier and the tubulointerstitium. Recent studies have shown that AA and its active derivative eicosanoids play important roles in the regulation of physiological kidney function and the pathogenesis of kidney disease. These factors are potentially novel biomarkers, especially in the context of their involvement in inflammatory processes and oxidative stress. In this review, we introduce the three main metabolic pathways of AA and discuss the molecular mechanisms by which these pathways affect the progression of acute kidney injury (AKI), diabetic nephropathy (DN) and renal cell carcinoma (RCC). This review may provide new therapeutic targets for the identification of AKI to CKD continuum.
Arachidonic acid (AA) is a main component of cell membrane lipids. AA is mainly metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP450). Esterified AA is hydrolysed by phospholipase A2 into a free form that is further metabolized by COX, LOX and CYP450 to a wide range of bioactive mediators, including prostaglandins, lipoxins, thromboxanes, leukotrienes, hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. Increased mitochondrial oxidative stress is considered to be a central mechanism in the pathophysiology of the kidney. Along with increased oxidative stress, apoptosis, inflammation and tissue fibrosis drive the progressive loss of kidney function, affecting the glomerular filtration barrier and the tubulointerstitium. Recent studies have shown that AA and its active derivative eicosanoids play important roles in the regulation of physiological kidney function and the pathogenesis of kidney disease. These factors are potentially novel biomarkers, especially in the context of their involvement in inflammatory processes and oxidative stress. In this review, we introduce the three main metabolic pathways of AA and discuss the molecular mechanisms by which these pathways affect the progression of acute kidney injury (AKI), diabetic nephropathy (DN) and renal cell carcinoma (RCC). This review may provide new therapeutic targets for the identification of AKI to CKD continuum.
Author Zhao, Ying-Yong
Li, Xiao-Jun
Miao, Hua
Nie, Xiao-Li
Suo, Ping
Wang, Yan-Ni
Zou, Liang
Author_xml – sequence: 1
  givenname: Xiao-Jun
  surname: Li
  fullname: Li, Xiao-Jun
– sequence: 2
  givenname: Ping
  surname: Suo
  fullname: Suo, Ping
– sequence: 3
  givenname: Yan-Ni
  surname: Wang
  fullname: Wang, Yan-Ni
– sequence: 4
  givenname: Liang
  surname: Zou
  fullname: Zou, Liang
– sequence: 5
  givenname: Xiao-Li
  surname: Nie
  fullname: Nie, Xiao-Li
– sequence: 6
  givenname: Ying-Yong
  surname: Zhao
  fullname: Zhao, Ying-Yong
– sequence: 7
  givenname: Hua
  surname: Miao
  fullname: Miao, Hua
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38523633$$D View this record in MEDLINE/PubMed
BookMark eNp9kU-P0zAQxS20iF2W_QIcUI5cUhzbccbHqvyrthIXOFsTe7L1KomL7R749qTbLkIc8GWs0e89W--9ZldznImxtw1fSQnmw3DYY1oJLtSqkboFLl6wm0ZrWRtoxNVf92t2l_MjX440Rmr1il1LaIXUUt6w3Tqh2wcf5-AqdMFXExXs4xjyVGGusCp7SnigY1mAgumBShXman2_rUusN_cfq5JwzqGEOL9hLwccM91d5i378fnT983Xevfty3az3tVONbLUXkneUatR6E4KP7SOkxS8B4OgsVNG-A6c9l2P2gxAAMpL1Rs1gFMD9fKWbc--PuKjPaQwYfplIwb7tIjpwWJa_juSHYzhvNdeLK5KAYDoyTtFwhEY3frF6_3Z65DizyPlYqeQHY0jzhSP2QoDbWdA6HZB313QYz-R__Pwc5oLAGfApZhzosG6UPCUzJJRGG3D7ak7-9SdPXVnL90tUvGP9Nn9P6Lf3xWboA
CitedBy_id crossref_primary_10_3389_fphar_2024_1504109
crossref_primary_10_1016_j_bcp_2024_116313
crossref_primary_10_3390_jcm13226772
crossref_primary_10_1007_s00018_024_05532_5
crossref_primary_10_1007_s42250_025_01218_y
crossref_primary_10_3389_fmicb_2025_1514115
Cites_doi 10.3390/biom10050703
10.1016/j.semcancer.2016.02.001
10.1016/j.freeradbiomed.2019.01.046
10.1371/journal.pone.0145645
10.1155/2013/612971
10.1074/jbc.M504055200
10.1016/s0891-5849(97)00463-2
10.1021/acs.biochem.8b00889
10.1016/j.intimp.2009.02.003
10.1038/onc.2012.161
10.3892/ijmm.13.5.665
10.1124/jpet.108.140889
10.1016/j.pharmthera.2008.05.008
10.1155/2015/147894
10.1021/cr200246d
10.1046/j.1523-1755.2003.00286.x
10.1371/journal.pone.0093182
10.1016/S0140-6736(19)32563-2
10.1152/ajprenal.90613.2008
10.1210/endrev/bnz010
10.1681/ASN.2015050528
10.1074/jbc.M105264200
10.3389/fphar.2022.1030800
10.1002/ijc.11646
10.1111/j.1523-1755.2005.00320.x
10.1152/ajprenal.00131.2007
10.1016/j.pharmthera.2005.02.004
10.3390/ijms18122661
10.1172/JCI111851
10.3109/08923973.2015.1127382
10.1681/ASN.2015040449
10.1016/0002-9343(84)90382-6
10.1038/s12276-019-0234-2
10.1161/01.HYP.0000153791.89776.43
10.1074/jbc.272.22.14139
10.1161/HYPERTENSIONAHA.114.03585
10.1073/pnas.1705615114
10.1681/ASN.2014030262
10.3389/fphar.2020.00828
10.1046/j.1523-1755.64.s87.15.x
10.3390/ijms22115452
10.1089/hum.2011.135
10.1161/HYPERTENSIONAHA.120.13898
10.1124/jpet.105.083477
10.1042/CS20130479
10.1016/s0090-6980(02)00026-6
10.1152/physrev.00044.2005
10.3390/ijms19071916
10.1152/ajprenal.1985.248.6.F779
10.1186/s10020-023-00762-y
10.1016/j.prostaglandins.2015.04.011
10.3389/fphar.2020.00819
10.1128/IAI.01505-13
10.1186/s12967-019-2054-5
10.1016/j.pharmthera.2018.10.010
10.1016/j.lfs.2020.118016
10.1111/febs.16609
10.1158/1535-7163.MCT-17-1299
10.1172/JCI13455
10.1177/039463200401700103
10.1016/j.pharmthera.2020.107670
10.4132/KoreanJPathol.2012.46.3.237
10.1053/j.ajkd.2017.10.026
10.1016/0002-9343(86)90928-9
10.1016/j.canlet.2012.01.022
10.1126/science.2820055
10.1016/j.intimp.2004.09.024
10.1016/j.ejphar.2020.173254
10.1002/cphy.c150009
10.1002/med.21596
10.1042/BJ20050582
10.1097/01.asn.0000099702.16315.de
10.1046/j.1523-1755.2000.00425.x
10.1042/CS20040125
10.1158/0008-5472.CAN-04-4173
10.1038/s41401-022-00947-x
10.1111/apha.13297
10.1046/j.1523-1755.2000.00148.x
10.1152/ajpendo.00624.2010
10.1002/mc.22092
10.1053/j.ackd.2005.01.004
10.1038/sj.embor.7400290
10.1016/j.phymed.2018.09.182
10.1097/MNH.0000000000000088
10.1016/j.bbalip.2014.08.012
10.1016/s0149-2918(02)80076-5
10.3390/ijms17050684
10.1091/mbc.E10-08-0665
10.1016/j.biopha.2020.110354
10.1124/jpet.106.115360
10.1172/JCI12367
10.1016/j.biopha.2018.12.034
10.14670/HH-22.1109
10.1038/s41585-019-0211-5
10.1016/s0024-3205(03)00180-2
10.1042/CS20050251
10.1016/j.canlet.2017.01.007
10.1016/j.pharmthera.2018.11.009
10.1152/ajpheart.00240.2010
10.2337/diabetes.55.01.06.db05-0831
10.2217/fon.14.152
10.1007/s10555-011-9310-3
10.1111/dom.12993
10.1016/j.bcp.2021.114732
10.1172/JCI72271
10.1155/2020/1809408
10.1016/0952-3278(92)90229-c
10.3389/fcimb.2020.557368
10.2337/db09-1241
10.1136/jech.55.5.338
10.1016/j.ancard.2018.04.018
10.1097/01.asn.0000019782.37851.bf
10.1172/JCI10228
10.3322/caac.21590
10.1073/pnas.95.21.12701
10.1152/ajprenal.00025.2004
10.1089/ars.2015.6372
10.1007/s00424-018-2183-3
10.1016/j.plipres.2018.11.001
10.1038/sj.ki.5001715
10.1038/ki.2012.115
10.1074/jbc.M110.187344
10.1007/s00280-010-1521-8
10.1158/0008-5472.CAN-06-3643
10.2337/diabetes.55.01.06.db05-0894
10.1007/s00134-021-06454-7
10.1038/sj.ki.5002192
10.3892/ijmm.13.1.41
10.3109/03602532.2013.806537
10.3892/ijmm.13.3.389
10.1152/ajprenal.2000.278.6.F949
10.1046/j.1523-1755.2002.00520.x
10.1172/jci.insight.155487
10.1093/cvr/cvab003
10.1371/journal.pone.0070029
10.1152/ajpendo.00591.2011
10.1158/0008-5472.CAN-10-0266
10.1161/01.res.88.1.44
10.1016/j.alit.2014.08.002
10.3390/biom11050730
10.1681/ASN.2014090868
10.1038/ki.2010.377
10.1681/ASN.2004070568
10.1136/thoraxjnl-2018-211845
10.1152/ajpheart.00783.2006
10.1038/ki.2008.600
10.1038/s41581-018-0001-y
10.1080/10408398.2020.1777932
10.1007/s11010-005-9038-x
10.1016/j.plefa.2004.06.004
10.1016/j.semnephrol.2019.12.002
10.1084/jem.20052124
10.1152/ajprenal.90268.2008
10.1124/jpet.109.152017
10.1016/j.prostaglandins.2017.11.002
10.1038/nrurol.2014.194
10.4049/jimmunol.164.4.2053
10.1016/j.freeradbiomed.2021.05.025
10.1146/annurev.physiol.63.1.579
10.1186/s12943-020-01266-7
10.1002/path.4121
10.1016/j.prostaglandins.2014.10.006
10.1152/ajprenal.00387.2007
10.3390/ijms20153683
10.1111/j.1349-7006.2010.01713.x
10.1038/41780
10.1128/mcb.19.3.1950
10.1016/j.eururo.2014.04.029
10.1681/ASN.2017030252
10.1016/j.jchromb.2014.03.015
10.2337/db08-1536
10.1073/pnas.2108094118
10.1159/000232399
10.1016/j.abb.2020.108623
10.1042/CS20130003
10.1038/ki.2010.331
10.1016/j.pharmthera.2018.06.015
ContentType Journal Article
Copyright Copyright © 2024 Li, Suo, Wang, Zou, Nie, Zhao and Miao.
Copyright_xml – notice: Copyright © 2024 Li, Suo, Wang, Zou, Nie, Zhao and Miao.
DBID AAYXX
CITATION
NPM
7X8
DOA
DOI 10.3389/fphar.2024.1365802
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1663-9812
ExternalDocumentID oai_doaj_org_article_f9900b6d2492448882bedc4e2ce8965d
38523633
10_3389_fphar_2024_1365802
Genre Journal Article
Review
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
ID FETCH-LOGICAL-c413t-d4307e56a26732df5c0e320b89a86a7492d78c6d7ba69f8e884d34b94f8c4feb3
IEDL.DBID M48
ISSN 1663-9812
IngestDate Wed Aug 27 01:29:53 EDT 2025
Sun Aug 24 03:48:29 EDT 2025
Thu Apr 03 06:57:59 EDT 2025
Thu Apr 24 22:50:57 EDT 2025
Tue Jul 01 02:53:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords arachidonic acid
chronic kidney disease
renal cell carcinoma
acute kidney injury
inflammation
oxidative stress
Language English
License Copyright © 2024 Li, Suo, Wang, Zou, Nie, Zhao and Miao.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c413t-d4307e56a26732df5c0e320b89a86a7492d78c6d7ba69f8e884d34b94f8c4feb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2024.1365802
PMID 38523633
PQID 2985798265
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_f9900b6d2492448882bedc4e2ce8965d
proquest_miscellaneous_2985798265
pubmed_primary_38523633
crossref_citationtrail_10_3389_fphar_2024_1365802
crossref_primary_10_3389_fphar_2024_1365802
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-00-00
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024-00-00
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pharmacology
PublicationTitleAlternate Front Pharmacol
PublicationYear 2024
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Dong (B34) 2020; 10
Li (B91) 2013; 32
Matsuyama (B100) 2005; 14
Puntarulo (B123) 1998; 24
Sodin-Semrl (B141) 2004; 17
Yuan (B177) 2008; 295
Burian (B15) 2005; 107
Linkermann (B93) 2014; 25
Yuan (B178) 2016; 24
Guo (B52) 2007; 321
Nakagawa (B110) 2012; 82
Dobrian (B33) 2019; 195
Faronato (B42) 2007; 22
Wang (B153) 2005; 314
Zheng (B183) 2020; 129
Jia (B75) 2011; 79
Cheng (B25) 2002; 62
Huang (B63) 2021; 61
Shuvy (B138) 2011; 300
Tengholm (B145) 2017; 19
Wender-Ozegowska (B157) 2004; 75
Eid (B37) 2013; 8
Kim (B85) 2005; 16
Meurer (B104) 2018; 470
Breyer (B13) 2005; 12
Yoshimura (B174); 13
Vukicevic (B149) 2006; 70
Evangelista (B39) 2020; 11
Wettersten (B158) 2020; 40
Williams (B159) 2007; 293
Hye Khan (B67) 2014; 127
Komers (B87) 2005; 67
Watanabe (B156) 2018; 134
Narumiya (B111) 2001; 108
Jia (B74) 2014; 9
Mccarthy (B102) 2015; 116
Papanikolaou (B119) 1992; 45
Garavito (B49) 2002
Woo (B161) 2015; 54
August (B7) 2003
Chen (B18); 134
Imig (B72) 2015; 6
Qian (B124) 2009; 113
Haeggström (B55) 2011; 111
Imig (B69) 2015; 65
Yoshimura (B173); 13
Zhu (B184) 2016; 11
Porro (B122) 2014; 964
Mcgowan (B103) 2001; 21
Green (B50) 2018; 57
Kim (B84) 2003; 64
Rådmark (B126) 2015; 1851
Chen (B22) 2004; 108
Nilakantan (B114) 2008; 294
Chen (B24) 2020; 695
Deng (B29) 2017; 114
Guo (B54) 2011; 300
Lee (B90) 2012; 46
Fishbein (B45) 2021; 218
Walshe (B150) 1984; 77
Elmarakby (B38) 2013; 125
Collins (B27) 2005; 280
Bhatt (B10) 2014; 11
Xu (B167) 2006; 55
Chen (B23) 2011; 22
Regner (B127) 2009; 75
Chen (B19) 2018; 50
Vivian (B148) 2002; 24
Alvarez (B3) 2021; 192
Zhao (B181) 2012; 23
Kawakami (B82) 2013; 229
Xu (B166) 2013; 45
Huerta (B64) 2001; 55
Muroya (B108) 2015; 26
Samuelsson (B131) 1987; 237
Wang (B152) 2019; 20
Dahly-Vernon (B28) 2005; 45
Aliwarga (B2) 2018; 19
Hamzaoui (B56) 2018; 67
Singh (B140) 2019; 73
Roche (B129) 2015; 120
Hoff (B60) 2011; 79
Yared (B171) 1985; 75
Reidy (B128) 2014; 124
Hansen-Petrik (B57) 2002; 62
Honda (B61) 2015; 64
Ito (B73) 2006; 284
Lytvyn (B96) 2020; 41
Yarla (B172) 2016
Ronco (B130) 2019; 394
Quigley (B125) 2000; 278
Zhang (B180) 2017; 391
Wang (B151) 2006; 203
Nithipatikom (B115) 2010; 101
Hyde (B66) 2009; 9
Nasrallah (B113) 2004; 287
Alexanian (B1) 2009; 29
Fan (B40) 2015; 24
Imig (B68) 2006; 111
Jia (B76) 2015; 2015
Sharma (B135) 2022; 7
Fleming (B47) 2001; 88
Sausville (B132) 2019; 196
Dey (B30) 2004; 107
Makino (B99) 2002; 13
Yu (B175) 2011; 68
Imig (B71) 2020; 76
Okumura (B117) 2003; 72
Asano (B6) 2002; 8
Wu (B163) 2021; 171
Jiang (B77) 2005; 65
Ma (B97) 2005; 72
Nasrallah (B112) 2016; 27
Anthonsen (B5) 2001; 276
Kopp (B89) 2019; 74
Komers (B86) 2001; 107
Kim (B83) 2012; 320
Siegel (B139) 2020; 70
Hutchinson (B65) 2008; 119
Kaminska (B79) 2014; 10
Zweifel (B185) 2002; 62
Chen (B20) 2012; 303
Fong (B48) 2021; 118
Hoff (B59) 2019; 227
Kar (B81) 2020; 256
Liu (B94) 2023; 290
Dillon (B32) 2010; 70
Wang (B155) 2023; 44
Ohba (B116) 2011; 31
Jiang (B78) 2007; 67
Luo (B95) 2009; 296
Turolo (B146) 2021; 22
Murai (B106) 2006; 395
Ching (B26) 2020; 11
Umanath (B147) 2018; 71
Fan (B41) 2017; 28
Feng (B44) 2020; 40
Schneider (B134) 2011; 30
Zhang (B179) 1997; 272
Hoxha (B62) 2019; 110
Ponsioen (B121) 2004; 5
Imig (B70) 2018; 192
Badimon (B8) 2021; 117
Pallàs (B118) 2020; 10
Schiffer (B133) 2001; 108
Borin (B12) 2017; 18
Xu (B168) 2010; 59
Bedard (B9) 2007; 87
Fitzgerald (B46) 2000; 164
Shuch (B137) 2015; 67
Eid (B36) 2009; 58
Wang (B154) 2020; 19
Dibona (B31) 1986; 80
Cai (B16) 2020; 882
Yang (B170) 2007; 293
Murata (B107) 1997; 388
Bonizzi (B11) 1999; 19
Chen (B21); 51
Makhov (B98) 2018; 17
Breyer (B14) 2001; 63
Kang (B80) 2003; 14
Pickkers (B120) 2021; 47
Sharma (B136) 2000; 58
Anders (B4) 2018; 14
Guo (B53) 2008; 327
Susztak (B143) 2006; 55
Feitoza (B43) 2005; 5
Yuan (B176) 2020; 2020
Linehan (B92) 2019; 16
Witola (B160) 2014; 82
Guan (B51) 2022; 13
Xu (B165) 2016; 17
Hao (B58) 2007; 71
Wu (B162) 2011; 286
Xiao (B164) 2016; 27
Chen (B17) 2009; 329
Kömhoff (B88) 2000; 58
Muthalif (B109) 1998; 95
Matsuyama (B101) 2004; 13
Yan (B169) 2021; 11
Edwards (B35) 1985; 248
Mohamed (B105) 2023; 29
Sun (B142) 2013; 2013
Sutariya (B144) 2016; 38
Zhao (B182) 2019; 17
References_xml – volume: 10
  start-page: 703
  year: 2020
  ident: B118
  article-title: Soluble epoxide hydrolase inhibition to face neuroinflammation in Parkinson's Disease: a new therapeutic strategy
  publication-title: Biomolecules
  doi: 10.3390/biom10050703
– start-page: 48
  year: 2016
  ident: B172
  article-title: Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2016.02.001
– volume: 134
  start-page: 484
  ident: B18
  article-title: Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2019.01.046
– volume: 11
  start-page: e0145645
  year: 2016
  ident: B184
  article-title: Renal ischemia/reperfusion injury in soluble epoxide hydrolase-deficient mice
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0145645
– volume: 2013
  start-page: 612971
  year: 2013
  ident: B142
  article-title: PPARγ agonist rosiglitazone suppresses renal mPGES-1/PGE2 pathway in db/db mice
  publication-title: PPAR Res.
  doi: 10.1155/2013/612971
– volume: 280
  start-page: 33157
  year: 2005
  ident: B27
  article-title: Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M504055200
– volume: 24
  start-page: 1324
  year: 1998
  ident: B123
  article-title: Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/s0891-5849(97)00463-2
– volume: 57
  start-page: 6726
  year: 2018
  ident: B50
  article-title: 5S,15S-dihydroperoxyeicosatetraenoic acid (5,15-diHpETE) as a lipoxin intermediate: reactivity and kinetics with human leukocyte 5-lipoxygenase, platelet 12-lipoxygenase, and reticulocyte 15-lipoxygenase-1
  publication-title: Biochemistry
  doi: 10.1021/acs.biochem.8b00889
– volume: 9
  start-page: 701
  year: 2009
  ident: B66
  article-title: Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2009.02.003
– volume: 32
  start-page: 1408
  year: 2013
  ident: B91
  article-title: PGE2 promotes renal carcinoma cell invasion through activated RalA
  publication-title: Oncogene
  doi: 10.1038/onc.2012.161
– volume: 13
  start-page: 665
  year: 2004
  ident: B101
  article-title: Lipoxygenase inhibitors prevent urological cancer cell growth
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.13.5.665
– volume: 327
  start-page: 10
  year: 2008
  ident: B53
  article-title: Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.108.140889
– volume: 119
  start-page: 291
  year: 2008
  ident: B65
  article-title: Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2008.05.008
– volume: 2015
  start-page: 147894
  year: 2015
  ident: B76
  article-title: Role of COX-2/mPGES-1/prostaglandin E2 cascade in kidney injury
  publication-title: Mediat. Inflamm.
  doi: 10.1155/2015/147894
– volume: 111
  start-page: 5866
  year: 2011
  ident: B55
  article-title: Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease
  publication-title: Chem. Rev.
  doi: 10.1021/cr200246d
– volume: 64
  start-page: 1702
  year: 2003
  ident: B84
  article-title: Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice
  publication-title: Kidney Int.
  doi: 10.1046/j.1523-1755.2003.00286.x
– volume: 9
  start-page: e93182
  year: 2014
  ident: B74
  article-title: COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0093182
– volume: 394
  start-page: 1949
  year: 2019
  ident: B130
  article-title: Acute kidney injury
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)32563-2
– volume: 296
  start-page: F556
  year: 2009
  ident: B95
  article-title: Glomerular 20-HETE, EETs, and TGF-β1 in diabetic nephropathy
  publication-title: Am. J. Physiol. Renal. Physiol.
  doi: 10.1152/ajprenal.90613.2008
– volume: 41
  start-page: 202
  year: 2020
  ident: B96
  article-title: The new biology of diabetic kidney disease-mechanisms and therapeutic implications
  publication-title: Endocr. Rev.
  doi: 10.1210/endrev/bnz010
– volume: 27
  start-page: 666
  year: 2016
  ident: B112
  article-title: PGE2, kidney disease, and cardiovascular risk: beyond hypertension and diabetes
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2015050528
– volume: 276
  start-page: 35344
  year: 2001
  ident: B5
  article-title: Atypical λ/ι PKC conveys 5-lipoxygenase/leukotriene B4-mediated cross-talk between phospholipase A2+s regulating NF-κB activation in response to tumor necrosis factor-α and interleukin-1β
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M105264200
– volume: 13
  start-page: 1030800
  year: 2022
  ident: B51
  article-title: Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2022.1030800
– volume: 108
  start-page: 825
  year: 2004
  ident: B22
  article-title: Significance of COX-2 expression in human renal cell carcinoma cell lines
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.11646
– volume: 67
  start-page: 2151
  year: 2005
  ident: B87
  article-title: Renal cyclooxygenase-2 in obese Zucker (fatty) rats
  publication-title: Kidney Int.
  doi: 10.1111/j.1523-1755.2005.00320.x
– volume: 293
  start-page: F501
  year: 2007
  ident: B159
  article-title: Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier
  publication-title: Am. J. Physiol. Renal. Physiol.
  doi: 10.1152/ajprenal.00131.2007
– volume: 107
  start-page: 139
  year: 2005
  ident: B15
  article-title: COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2005.02.004
– volume: 18
  start-page: 2661
  year: 2017
  ident: B12
  article-title: Arachidonic acid metabolite as a novel therapeutic target in breast cancer metastasis
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms18122661
– volume: 75
  start-page: 1477
  year: 1985
  ident: B171
  article-title: Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI111851
– volume: 38
  start-page: 39
  year: 2016
  ident: B144
  article-title: TGF-β: the connecting link between nephropathy and fibrosis
  publication-title: Immunopharmacol. Immunotoxicol.
  doi: 10.3109/08923973.2015.1127382
– volume: 27
  start-page: 1727
  year: 2016
  ident: B164
  article-title: Sustained activation of Wnt/β-catenin signaling drives AKI to CKD progression
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2015040449
– volume: 77
  start-page: 765
  year: 1984
  ident: B150
  article-title: Abdominal pain associated with IgA nephropathy. Possible mechanism
  publication-title: Am. J. Med.
  doi: 10.1016/0002-9343(84)90382-6
– volume: 51
  start-page: 38
  ident: B21
  article-title: Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-019-0234-2
– volume: 45
  start-page: 643
  year: 2005
  ident: B28
  article-title: Transforming growth factor-β, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000153791.89776.43
– volume: 272
  start-page: 14139
  year: 1997
  ident: B179
  article-title: Epidermal growth factor induces CD44 gene expression through a novel regulatory element in mouse fibroblasts
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.272.22.14139
– volume: 65
  start-page: 476
  year: 2015
  ident: B69
  article-title: Epoxyeicosatrienoic acids, hypertension, and kidney injury
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.114.03585
– volume: 114
  start-page: 12608
  year: 2017
  ident: B29
  article-title: Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1705615114
– volume: 25
  start-page: 2689
  year: 2014
  ident: B93
  article-title: Regulated cell death in AKI
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2014030262
– volume: 11
  start-page: 828
  year: 2020
  ident: B39
  article-title: Expression and function of eicosanoid-producing cytochrome P450 enzymes in solid tumors
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2020.00828
– start-page: S99
  year: 2003
  ident: B7
  article-title: Transforming growth factor beta and progression of renal disease
  publication-title: Kidney Int.
  doi: 10.1046/j.1523-1755.64.s87.15.x
– volume: 22
  start-page: 5452
  year: 2021
  ident: B146
  article-title: Role of arachidonic acid and its metabolites in the biological and clinical manifestations of idiopathic nephrotic syndrome
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms22115452
– volume: 23
  start-page: 688
  year: 2012
  ident: B181
  article-title: Delivery of AAV2-CYP2J2 protects remnant kidney in the 5/6-nephrectomized rat via inhibition of apoptosis and fibrosis
  publication-title: Hum. Gene Ther.
  doi: 10.1089/hum.2011.135
– volume: 76
  start-page: 3
  year: 2020
  ident: B71
  article-title: Epoxy fatty acids: from salt regulation to kidney and cardiovascular therapeutics: 2019 Lewis K. Dahl memorial lecture
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.120.13898
– volume: 31
  start-page: 597
  year: 2011
  ident: B116
  article-title: Clinical significance and predictive value of prostaglandin E2 receptors (EPR) 1 - 4 in patients with renal cell carcinoma
  publication-title: Anticancer Res.
– volume: 314
  start-page: 522
  year: 2005
  ident: B153
  article-title: Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.105.083477
– volume: 127
  start-page: 463
  year: 2014
  ident: B67
  article-title: Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition
  publication-title: Clin. Sci. (Lond)
  doi: 10.1042/CS20130479
– start-page: 129
  year: 2002
  ident: B49
  article-title: The structures of prostaglandin endoperoxide H synthases-1 and -2
  publication-title: Prostaglandins Other Lipid Mediat.
  doi: 10.1016/s0090-6980(02)00026-6
– volume: 87
  start-page: 245
  year: 2007
  ident: B9
  article-title: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00044.2005
– volume: 19
  start-page: 1916
  year: 2018
  ident: B2
  article-title: Regulation of CYP2J2 and EET levels in cardiac disease and diabetes
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms19071916
– volume: 248
  start-page: F779
  year: 1985
  ident: B35
  article-title: Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles
  publication-title: Am. J. Physiol.
  doi: 10.1152/ajprenal.1985.248.6.F779
– volume: 29
  start-page: 163
  year: 2023
  ident: B105
  article-title: Sustained activation of 12/15 lipoxygenase (12/15 LOX) contributes to impaired renal recovery post ischemic injury in male SHR compared to females
  publication-title: Mol. Med.
  doi: 10.1186/s10020-023-00762-y
– volume: 120
  start-page: 148
  year: 2015
  ident: B129
  article-title: Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice
  publication-title: Prostaglandins Other Lipid Mediat.
  doi: 10.1016/j.prostaglandins.2015.04.011
– volume: 11
  start-page: 819
  year: 2020
  ident: B26
  article-title: Eicosanoids in cancer: prostaglandin E2 receptor 4 in cancer therapeutics and immunotherapy
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2020.00819
– volume: 82
  start-page: 2670
  year: 2014
  ident: B160
  article-title: ALOX12 in human toxoplasmosis
  publication-title: Infect. Immun.
  doi: 10.1128/IAI.01505-13
– volume: 17
  start-page: 302
  year: 2019
  ident: B182
  article-title: Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-019-2054-5
– volume: 195
  start-page: 100
  year: 2019
  ident: B33
  article-title: Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2018.10.010
– volume: 256
  start-page: 118016
  year: 2020
  ident: B81
  article-title: Curcumin and LOXblock-1 ameliorate ischemia-reperfusion induced inflammation and acute kidney injury by suppressing the semaphorin-plexin pathway
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2020.118016
– volume: 290
  start-page: 533
  year: 2023
  ident: B94
  article-title: PGE2 pathway mediates oxidative stress-induced ferroptosis in renal tubular epithelial cells
  publication-title: FEBS J.
  doi: 10.1111/febs.16609
– volume: 17
  start-page: 1355
  year: 2018
  ident: B98
  article-title: Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-17-1299
– volume: 108
  start-page: 25
  year: 2001
  ident: B111
  article-title: Genetic and pharmacological analysis of prostanoid receptor function
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI13455
– volume: 17
  start-page: 15
  year: 2004
  ident: B141
  article-title: Lipoxin A4 counteracts synergistic activation of human fibroblast-like synoviocytes
  publication-title: Int. J. Immunopathol. Pharmacol.
  doi: 10.1177/039463200401700103
– volume: 218
  start-page: 107670
  year: 2021
  ident: B45
  article-title: Carcinogenesis: failure of resolution of inflammation?
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2020.107670
– volume: 46
  start-page: 237
  year: 2012
  ident: B90
  article-title: Cyclooxygenase-2 expression and its prognostic significance in clear cell renal cell carcinoma
  publication-title: Korean J. Pathol.
  doi: 10.4132/KoreanJPathol.2012.46.3.237
– volume: 71
  start-page: 884
  year: 2018
  ident: B147
  article-title: Update on diabetic nephropathy: core curriculum 2018
  publication-title: Am. J. Kidney Dis.
  doi: 10.1053/j.ajkd.2017.10.026
– volume: 80
  start-page: 12
  year: 1986
  ident: B31
  article-title: Prostaglandins and nonsteroidal anti-inflammatory drugs. Effects on renal hemodynamics
  publication-title: Am. J. Med.
  doi: 10.1016/0002-9343(86)90928-9
– volume: 320
  start-page: 65
  year: 2012
  ident: B83
  article-title: Rap1GAP regulates renal cell carcinoma invasion
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2012.01.022
– volume: 8
  start-page: 1157
  year: 2002
  ident: B6
  article-title: Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression
  publication-title: Clin. Cancer Res.
– volume: 237
  start-page: 1171
  year: 1987
  ident: B131
  article-title: Leukotrienes and lipoxins: structures, biosynthesis, and biological effects
  publication-title: Science
  doi: 10.1126/science.2820055
– volume: 5
  start-page: 79
  year: 2005
  ident: B43
  article-title: Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2004.09.024
– volume: 882
  start-page: 173254
  year: 2020
  ident: B16
  article-title: Effects of thromboxane prostanoid receptor deficiency on diabetic nephropathy induced by high fat diet and streptozotocin in mice
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2020.173254
– volume: 6
  start-page: 423
  year: 2015
  ident: B72
  article-title: Cytochrome P450 and lipoxygenase metabolites on renal function
  publication-title: Compr. Physiol.
  doi: 10.1002/cphy.c150009
– volume: 40
  start-page: 54
  year: 2020
  ident: B44
  article-title: Small molecule inhibitors of epithelial-mesenchymal transition for the treatment of cancer and fibrosis
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.21596
– volume: 395
  start-page: 65
  year: 2006
  ident: B106
  article-title: Epidermal growth factor-regulated activation of Rac GTPase enhances CD44 cleavage by metalloproteinase disintegrin ADAM10
  publication-title: Biochem. J.
  doi: 10.1042/BJ20050582
– volume: 14
  start-page: 3178
  year: 2003
  ident: B80
  article-title: Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen α5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1097/01.asn.0000099702.16315.de
– volume: 58
  start-page: 2420
  year: 2000
  ident: B88
  article-title: Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome
  publication-title: Kidney Int.
  doi: 10.1046/j.1523-1755.2000.00425.x
– volume: 62
  start-page: 403
  year: 2002
  ident: B57
  article-title: Prostaglandin E2 protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice
  publication-title: Cancer Res.
– volume: 107
  start-page: 561
  year: 2004
  ident: B30
  article-title: Rofecoxib decreases renal injury in obese Zucker rats
  publication-title: Clin. Sci. (Lond)
  doi: 10.1042/CS20040125
– volume: 65
  start-page: 4707
  year: 2005
  ident: B77
  article-title: Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-4173
– volume: 44
  start-page: 393
  year: 2023
  ident: B155
  article-title: Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease
  publication-title: Acta Pharmacol. Sin.
  doi: 10.1038/s41401-022-00947-x
– volume: 62
  start-page: 6706
  year: 2002
  ident: B185
  article-title: Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors
  publication-title: Cancer Res.
– volume: 227
  start-page: e13297
  year: 2019
  ident: B59
  article-title: A synthetic epoxyeicosatrienoic acid analogue prevents the initiation of ischemic acute kidney injury
  publication-title: Acta Physiol. (Oxf)
  doi: 10.1111/apha.13297
– volume: 58
  start-page: 131
  year: 2000
  ident: B136
  article-title: Transforming growth factor-β1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals
  publication-title: Kidney Int.
  doi: 10.1046/j.1523-1755.2000.00148.x
– volume: 300
  start-page: E708
  year: 2011
  ident: B54
  article-title: Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00624.2010
– volume: 54
  start-page: 216
  year: 2015
  ident: B161
  article-title: Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways
  publication-title: Mol. Carcinog.
  doi: 10.1002/mc.22092
– volume: 12
  start-page: 128
  year: 2005
  ident: B13
  article-title: Diabetic nephropathy: of mice and men
  publication-title: Adv. Chronic Kidney Dis.
  doi: 10.1053/j.ackd.2005.01.004
– volume: 5
  start-page: 1176
  year: 2004
  ident: B121
  article-title: Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator
  publication-title: EMBO Rep.
  doi: 10.1038/sj.embor.7400290
– volume: 50
  start-page: 50
  year: 2018
  ident: B19
  article-title: Natural products for the prevention and treatment of kidney disease
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2018.09.182
– volume: 24
  start-page: 37
  year: 2015
  ident: B40
  article-title: Cytochrome P450 eicosanoids in hypertension and renal disease
  publication-title: Curr. Opin. Nephrol. Hypertens.
  doi: 10.1097/MNH.0000000000000088
– volume: 1851
  start-page: 331
  year: 2015
  ident: B126
  article-title: 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbalip.2014.08.012
– volume: 24
  start-page: 1741
  year: 2002
  ident: B148
  article-title: Pharmacologic management of diabetic nephropathy
  publication-title: Clin. Ther.
  doi: 10.1016/s0149-2918(02)80076-5
– volume: 17
  start-page: 684
  year: 2016
  ident: B165
  article-title: 12-Lipoxygenase inhibition on microalbuminuria in type-1 and type-2 diabetes is associated with changes of glomerular angiotensin II type 1 receptor related to insulin resistance
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms17050684
– volume: 22
  start-page: 141
  year: 2011
  ident: B23
  article-title: A Ral GAP complex links PI3-kinase/Akt signaling to RalA activation in insulin action
  publication-title: Mol. Biol. Cell.
  doi: 10.1091/mbc.E10-08-0665
– volume: 129
  start-page: 110354
  year: 2020
  ident: B183
  article-title: The biological role of arachidonic acid 12-lipoxygenase (ALOX12) in various human diseases
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2020.110354
– volume: 321
  start-page: 18
  year: 2007
  ident: B52
  article-title: Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.106.115360
– volume: 108
  start-page: 807
  year: 2001
  ident: B133
  article-title: Apoptosis in podocytes induced by TGF-β and Smad7
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI12367
– volume: 110
  start-page: 796
  year: 2019
  ident: B62
  article-title: Duchenne muscular dystrophy: focus on arachidonic acid metabolites
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2018.12.034
– volume: 22
  start-page: 1109
  year: 2007
  ident: B42
  article-title: Increased expression of 5-lipoxygenase is common in clear cell renal cell carcinoma
  publication-title: Histol. Histopathol.
  doi: 10.14670/HH-22.1109
– volume: 16
  start-page: 539
  year: 2019
  ident: B92
  article-title: The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/s41585-019-0211-5
– volume: 72
  start-page: 2695
  year: 2003
  ident: B117
  article-title: Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats
  publication-title: Life Sci.
  doi: 10.1016/s0024-3205(03)00180-2
– volume: 111
  start-page: 21
  year: 2006
  ident: B68
  article-title: Eicosanoids and renal vascular function in diseases
  publication-title: Clin. Sci. (Lond)
  doi: 10.1042/CS20050251
– volume: 75
  start-page: 385
  year: 2004
  ident: B157
  article-title: Vascular complications and their effect on fetal-maternal outcome and therapeutic approach in diabetic women
  publication-title: Ginekol. Pol.
– volume: 391
  start-page: 50
  year: 2017
  ident: B180
  article-title: Prostaglandin E2 receptor 4 mediates renal cell carcinoma intravasation and metastasis
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2017.01.007
– volume: 29
  start-page: 3819
  year: 2009
  ident: B1
  article-title: Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth
  publication-title: Anticancer Res.
– volume: 14
  start-page: 73
  year: 2005
  ident: B100
  article-title: 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway
  publication-title: Oncol. Rep.
– volume: 196
  start-page: 183
  year: 2019
  ident: B132
  article-title: Cytochrome P450 epoxygenases and cancer: a genetic and a molecular perspective
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2018.11.009
– volume: 300
  start-page: H1829
  year: 2011
  ident: B138
  article-title: Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure
  publication-title: Am. J. Physiol. Heart Circ. Physiol.
  doi: 10.1152/ajpheart.00240.2010
– volume: 55
  start-page: 110
  year: 2006
  ident: B167
  article-title: The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice
  publication-title: Diabetes
  doi: 10.2337/diabetes.55.01.06.db05-0831
– volume: 10
  start-page: 2177
  year: 2014
  ident: B79
  article-title: The role of prostaglandin E2 in renal cell cancer development: future implications for prognosis and therapy
  publication-title: Future Oncol.
  doi: 10.2217/fon.14.152
– volume: 30
  start-page: 277
  year: 2011
  ident: B134
  article-title: Cyclooxygenases and lipoxygenases in cancer
  publication-title: Cancer Metastasis Rev.
  doi: 10.1007/s10555-011-9310-3
– volume: 19
  start-page: 42
  year: 2017
  ident: B145
  article-title: cAMP signalling in insulin and glucagon secretion
  publication-title: Diabetes Obes. Metab.
  doi: 10.1111/dom.12993
– volume: 192
  start-page: 114732
  year: 2021
  ident: B3
  article-title: Role of eicosanoids in liver repair, regeneration and cancer
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2021.114732
– volume: 124
  start-page: 2333
  year: 2014
  ident: B128
  article-title: Molecular mechanisms of diabetic kidney disease
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI72271
– volume: 2020
  start-page: 1809408
  year: 2020
  ident: B176
  article-title: The role of Notch3 signaling in kidney disease
  publication-title: Oxid. Med. Cell. Longev.
  doi: 10.1155/2020/1809408
– volume: 45
  start-page: 131
  year: 1992
  ident: B119
  article-title: Does gentamicin induce acute renal failure by increasing renal TXA2 synthesis in rats?
  publication-title: Prostagl. Leukot. Essent. Fat. Acids
  doi: 10.1016/0952-3278(92)90229-c
– volume: 10
  start-page: 557368
  year: 2020
  ident: B34
  article-title: A comparative study of the gut microbiota associated with immunoglobulin A nephropathy and membranous nephropathy
  publication-title: Front. Cell. Infect. Microbiol.
  doi: 10.3389/fcimb.2020.557368
– volume: 59
  start-page: 997
  year: 2010
  ident: B168
  article-title: Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice
  publication-title: Diabetes
  doi: 10.2337/db09-1241
– volume: 55
  start-page: 338
  year: 2001
  ident: B64
  article-title: Incidence of ocular melanoma in the general population and in glaucoma patients
  publication-title: J. Epidemiol. Community Health
  doi: 10.1136/jech.55.5.338
– volume: 67
  start-page: 141
  year: 2018
  ident: B56
  article-title: Cardiovascular consequences of chronic kidney disease, impact of modulation of epoxyeicosatrienoic acids
  publication-title: Ann. Cardiol. Angeiol. (Paris)
  doi: 10.1016/j.ancard.2018.04.018
– volume: 13
  start-page: 1757
  year: 2002
  ident: B99
  article-title: Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1097/01.asn.0000019782.37851.bf
– volume: 107
  start-page: 889
  year: 2001
  ident: B86
  article-title: Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI10228
– volume: 70
  start-page: 7
  year: 2020
  ident: B139
  article-title: Cancer statistics, 2020
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21590
– volume: 95
  start-page: 12701
  year: 1998
  ident: B109
  article-title: 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.95.21.12701
– volume: 287
  start-page: F673
  year: 2004
  ident: B113
  article-title: Reduced IP receptors in STZ-induced diabetic rat kidneys and high-glucose-treated mesangial cells
  publication-title: Am. J. Physiol. Renal. Physiol.
  doi: 10.1152/ajprenal.00025.2004
– volume: 24
  start-page: 361
  year: 2016
  ident: B178
  article-title: Epigenetic histone modifications involved in profibrotic gene regulation by 12/15-lipoxygenase and its oxidized lipid products in diabetic nephropathy
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2015.6372
– volume: 470
  start-page: 1691
  year: 2018
  ident: B104
  article-title: The renal vasodilatory effect of prostaglandins is ameliorated in isolated-perfused kidneys of endotoxemic mice
  publication-title: Pflugers Arch.
  doi: 10.1007/s00424-018-2183-3
– volume: 73
  start-page: 28
  year: 2019
  ident: B140
  article-title: Emerging role of 12/15-lipoxygenase (ALOX15) in human pathologies
  publication-title: Prog. Lipid Res.
  doi: 10.1016/j.plipres.2018.11.001
– volume: 70
  start-page: 1099
  year: 2006
  ident: B149
  article-title: Role of EP2 and EP4 receptor-selective agonists of prostaglandin E2 in acute and chronic kidney failure
  publication-title: Kidney Int.
  doi: 10.1038/sj.ki.5001715
– volume: 82
  start-page: 158
  year: 2012
  ident: B110
  article-title: The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice
  publication-title: Kidney Int.
  doi: 10.1038/ki.2012.115
– volume: 286
  start-page: 33954
  year: 2011
  ident: B162
  article-title: Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.187344
– volume: 68
  start-page: 619
  year: 2011
  ident: B175
  article-title: Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer
  publication-title: Cancer Chemother. Pharmacol.
  doi: 10.1007/s00280-010-1521-8
– volume: 67
  start-page: 6665
  year: 2007
  ident: B78
  article-title: Cytochrome p450 epoxygenase promotes human cancer metastasis
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-3643
– volume: 55
  start-page: 225
  year: 2006
  ident: B143
  article-title: Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy
  publication-title: Diabetes
  doi: 10.2337/diabetes.55.01.06.db05-0894
– volume: 47
  start-page: 835
  year: 2021
  ident: B120
  article-title: Acute kidney injury in the critically ill: an updated review on pathophysiology and management
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-021-06454-7
– volume: 71
  start-page: 1105
  year: 2007
  ident: B58
  article-title: Physiologic and pathophysiologic roles of lipid mediators in the kidney
  publication-title: Kidney Int.
  doi: 10.1038/sj.ki.5002192
– volume: 21
  start-page: 111
  year: 2001
  ident: B103
  article-title: Diabetic nephropathy
  publication-title: Clin. Lab. Med.
– volume: 13
  start-page: 41
  ident: B173
  article-title: Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.13.1.41
– volume: 45
  start-page: 311
  year: 2013
  ident: B166
  article-title: Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance
  publication-title: Drug Metab. Rev.
  doi: 10.3109/03602532.2013.806537
– volume: 13
  start-page: 389
  ident: B174
  article-title: Relationship between lipoxygenase and human testicular cancer
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.13.3.389
– volume: 278
  start-page: F949
  year: 2000
  ident: B125
  article-title: Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport
  publication-title: Am. J. Physiol. Renal. Physiol.
  doi: 10.1152/ajprenal.2000.278.6.F949
– volume: 62
  start-page: 929
  year: 2002
  ident: B25
  article-title: Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension
  publication-title: Kidney Int.
  doi: 10.1046/j.1523-1755.2002.00520.x
– volume: 7
  start-page: e155487
  year: 2022
  ident: B135
  article-title: Modulation of gentamicin-induced acute kidney injury by myo-inositol oxygenase via the ROS/ALOX-12/12-HETE/GPR31 signaling pathway
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.155487
– volume: 117
  start-page: 2001
  year: 2021
  ident: B8
  article-title: The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvab003
– volume: 8
  start-page: e70029
  year: 2013
  ident: B37
  article-title: 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0070029
– volume: 303
  start-page: E563
  year: 2012
  ident: B20
  article-title: Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00591.2011
– volume: 70
  start-page: 4260
  year: 2010
  ident: B32
  article-title: Distinct biological roles for the akt family in mammary tumor progression
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-0266
– volume: 88
  start-page: 44
  year: 2001
  ident: B47
  article-title: Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries
  publication-title: Circ. Res.
  doi: 10.1161/01.res.88.1.44
– volume: 64
  start-page: 11
  year: 2015
  ident: B61
  article-title: Prostanoids in allergy
  publication-title: Allergol. Int.
  doi: 10.1016/j.alit.2014.08.002
– volume: 11
  start-page: 730
  year: 2021
  ident: B169
  article-title: NADH/NAD+ redox imbalance and diabetic kidney disease
  publication-title: Biomolecules
  doi: 10.3390/biom11050730
– volume: 26
  start-page: 2460
  year: 2015
  ident: B108
  article-title: Deficiency in the formation of 20-hydroxyeicosatetraenoic acid enhances renal ischemia-reperfusion injury
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2014090868
– volume: 79
  start-page: 57
  year: 2011
  ident: B60
  article-title: Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury
  publication-title: Kidney Int.
  doi: 10.1038/ki.2010.377
– volume: 16
  start-page: 352
  year: 2005
  ident: B85
  article-title: Novel interactions between TGF-β1 actions and the 12/15-lipoxygenase pathway in mesangial cells
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2004070568
– volume: 74
  start-page: 237
  year: 2019
  ident: B89
  article-title: Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2018-211845
– volume: 293
  start-page: H142
  year: 2007
  ident: B170
  article-title: Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-α via MAPK and PI3K/Akt signaling pathways
  publication-title: Am. J. Physiol. Heart Circ. Physiol.
  doi: 10.1152/ajpheart.00783.2006
– volume: 75
  start-page: 511
  year: 2009
  ident: B127
  article-title: Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury
  publication-title: Kidney Int.
  doi: 10.1038/ki.2008.600
– volume: 14
  start-page: 361
  year: 2018
  ident: B4
  article-title: CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
  publication-title: Nat. Rev. Nephrol.
  doi: 10.1038/s41581-018-0001-y
– volume: 61
  start-page: 2399
  year: 2021
  ident: B63
  article-title: Role of arachidonic acid-derived eicosanoids in intestinal innate immunity
  publication-title: Crit. Rev. Food Sci. Nutr.
  doi: 10.1080/10408398.2020.1777932
– volume: 284
  start-page: 141
  year: 2006
  ident: B73
  article-title: Expression of cytochrome P-450 4 enzymes in the kidney and liver: regulation by PPAR and species-difference between rat and human
  publication-title: Mol. Cell. Biochem.
  doi: 10.1007/s11010-005-9038-x
– volume: 72
  start-page: 13
  year: 2005
  ident: B97
  article-title: 12/15-lipoxygenase inhibitors in diabetic nephropathy in the rat
  publication-title: Prostaglandins Leukot. Essent. Fatty Acids
  doi: 10.1016/j.plefa.2004.06.004
– volume: 40
  start-page: 2
  year: 2020
  ident: B158
  article-title: Reprogramming of metabolism in kidney cancer
  publication-title: Semin. Nephrol.
  doi: 10.1016/j.semnephrol.2019.12.002
– volume: 203
  start-page: 941
  year: 2006
  ident: B151
  article-title: CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20052124
– volume: 295
  start-page: F605
  year: 2008
  ident: B177
  article-title: Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes
  publication-title: Am. J. Physiol. Renal. Physiol.
  doi: 10.1152/ajprenal.90268.2008
– volume: 329
  start-page: 908
  year: 2009
  ident: B17
  article-title: Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.109.152017
– volume: 134
  start-page: 16
  year: 2018
  ident: B156
  article-title: 7-Ketocholesterol induces ROS-mediated mRNA expression of 12-lipoxygenase, cyclooxygenase-2 and pro-inflammatory cytokines in human mesangial cells: potential role in diabetic nephropathy
  publication-title: Prostaglandins Other Lipid Mediat.
  doi: 10.1016/j.prostaglandins.2017.11.002
– volume: 11
  start-page: 517
  year: 2014
  ident: B10
  article-title: Landmarks in the diagnosis and treatment of renal cell carcinoma
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/nrurol.2014.194
– volume: 164
  start-page: 2053
  year: 2000
  ident: B46
  article-title: Ras, protein kinase Cζ, and IκB kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-κB by hyaluronic acid fragments in T-24 carcinoma cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.164.4.2053
– volume: 171
  start-page: 260
  year: 2021
  ident: B163
  article-title: AGE/RAGE in diabetic kidney disease and ageing kidney
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2021.05.025
– volume: 63
  start-page: 579
  year: 2001
  ident: B14
  article-title: G protein-coupled prostanoid receptors and the kidney
  publication-title: Annu. Rev. Physiol.
  doi: 10.1146/annurev.physiol.63.1.579
– volume: 19
  start-page: 149
  year: 2020
  ident: B154
  article-title: Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-020-01266-7
– volume: 229
  start-page: 221
  year: 2013
  ident: B82
  article-title: Wnt signalling in kidney diseases: dual roles in renal injury and repair
  publication-title: J. Pathol.
  doi: 10.1002/path.4121
– volume: 116
  start-page: 88
  year: 2015
  ident: B102
  article-title: Ethanol at low concentrations protects glomerular podocytes through alcohol dehydrogenase and 20-HETE
  publication-title: Prostaglandins Other Lipid Mediat.
  doi: 10.1016/j.prostaglandins.2014.10.006
– volume: 294
  start-page: F562
  year: 2008
  ident: B114
  article-title: 20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells
  publication-title: Am. J. Physiol. Renal. Physiol.
  doi: 10.1152/ajprenal.00387.2007
– volume: 20
  start-page: 3683
  year: 2019
  ident: B152
  article-title: Arachidonic acid metabolism and kidney inflammation
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20153683
– volume: 101
  start-page: 2629
  year: 2010
  ident: B115
  article-title: Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists
  publication-title: Cancer Sci.
  doi: 10.1111/j.1349-7006.2010.01713.x
– volume: 388
  start-page: 678
  year: 1997
  ident: B107
  article-title: Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
  publication-title: Nature
  doi: 10.1038/41780
– volume: 19
  start-page: 1950
  year: 1999
  ident: B11
  article-title: Reactive oxygen intermediate-dependent NF-κB activation by interleukin-1β requires 5-lipoxygenase or NADPH oxidase activity
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/mcb.19.3.1950
– volume: 67
  start-page: 85
  year: 2015
  ident: B137
  article-title: Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2014.04.029
– volume: 28
  start-page: 2845
  year: 2017
  ident: B41
  article-title: Effect of cytochrome P450 metabolites of arachidonic acid in nephrology
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2017030252
– volume: 964
  start-page: 26
  year: 2014
  ident: B122
  article-title: Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product
  publication-title: J. Chromatogr. B Anal. Technol. Biomed. Life Sci.
  doi: 10.1016/j.jchromb.2014.03.015
– volume: 58
  start-page: 1201
  year: 2009
  ident: B36
  article-title: Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases
  publication-title: Diabetes
  doi: 10.2337/db08-1536
– volume: 118
  start-page: e2108094118
  year: 2021
  ident: B48
  article-title: Regulation of P2X1 receptors by modulators of the cAMP effectors PKA and EPAC
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.2108094118
– volume: 113
  start-page: p7
  year: 2009
  ident: B124
  article-title: PGE2 causes mesangial cell hypertrophy and decreases expression of cyclin D3
  publication-title: Nephron Physiol.
  doi: 10.1159/000232399
– volume: 695
  start-page: 108623
  year: 2020
  ident: B24
  article-title: Metabolomics in renal cell carcinoma: from biomarker identification to pathomechanism insights
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1016/j.abb.2020.108623
– volume: 125
  start-page: 349
  year: 2013
  ident: B38
  article-title: Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats
  publication-title: Clin. Sci. (Lond)
  doi: 10.1042/CS20130003
– volume: 79
  start-page: 77
  year: 2011
  ident: B75
  article-title: Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis
  publication-title: Kidney Int.
  doi: 10.1038/ki.2010.331
– volume: 192
  start-page: 1
  year: 2018
  ident: B70
  article-title: Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2018.06.015
SSID ssj0000399364
Score 2.4266877
SecondaryResourceType review_article
Snippet Arachidonic acid (AA) is a main component of cell membrane lipids. AA is mainly metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and...
SourceID doaj
proquest
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
StartPage 1365802
SubjectTerms acute kidney injury
arachidonic acid
chronic kidney disease
inflammation
oxidative stress
renal cell carcinoma
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUqTr1U0A9YKMiVKi5gEWzHsY8LBdFSVRxA4mY5_hArQRax4cC_Z8bOLnspXLhGtuK8GXvmOeNnQn76wIWMoWaCx4ZJpziDLKNmhlc-CJ94crlA9p86u5J_ruvrpau-sCasyAMX4A4SLJdVqwIq2wGVgISwjcHLyH3URtUBV9_KVEtkKq_BGHeVLKdkgIWZg3R_41D_k8tc2aWHfZR5JMqC_f_PMnO0OV0ln4Y0kY7L8NbIh9h9JrsXRWf6aZ9evhybmu3TXXrxokD99IX8HT9gjWRA2Vvq_CTQu9iDtW8nszvqZtTRpWNXtBSD00lHx-e_WT9lx-e_aI8xLJdzfSVXpyeXx2dsuDaBeYhIPQsS5m2sleOqETyk2ldR8KrVxmnlGsAxNNqr0LROmaSj1jII2RqZtJcJyPU3stJNu7hBKIZzbiLM6ZSgX2VaxF9F6ZpWgzFG5HAOofWDpjhebXFrgVsg7DbDbhF2O8A-InuLPvdFUePV1kdomUVLVMPOD8BH7OAj9i0fGZEfc7tamD34S8R1cfo4s9zoujFAseoRWS8GX7xKaCDpSojN9xjCFvmIn1U2b76Tlf7hMW5DOtO3O9lznwESxPAO
  priority: 102
  providerName: Directory of Open Access Journals
Title Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition
URI https://www.ncbi.nlm.nih.gov/pubmed/38523633
https://www.proquest.com/docview/2985798265
https://doaj.org/article/f9900b6d2492448882bedc4e2ce8965d
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaqcuGCeLM8KldCvVBDajuOfajQ0lIVilAPXak3y_GjrLTNlk0qsf--M052CxJF4pjITqwZj78Ze_wNIW994ELGUDLBY8WkU5yBl1EywwsfhE88uZwg-10dT-TX8_J8g6zKHQ0CbP8a2mE9qcli9v7Xz-VHMPh9jDgBbz-kqx8OqT25zElbGrkl7-XzIkzlG9z9vDIjGmdGqT0AWmYA3Pp7NHd85g-sypT-d_uhGY-OHpIHgyNJx73mH5GN2DwmO6c9E_Vyl57dXqxqd-kOPb3lqF4-Id_GC8yiDEiMS52fBnoZO5gPs2l7SV1LHf3tYhbt08XptKHjky-sm7ODk0PaIcrlhK-nZHL0-ezgmA2FFZgHqXQsSLDsWCrHVSV4SKUvouBFrY3TylXS8FBpr0JVO2WSjlrLIGRtZNJeJgi_n5HNZt7EF4Qi4HMTwepTgn6FqcFlr1WUrqo1LA4jsrcSofUD6zgWv5hZiD5Q7DaL3aLY7SD2EXm37nPVc278s_Un1My6JfJl5xfzxYUdzM8mAN2iVgH5ESEgxTHG4GXkPmqjyjAi2yu9WrAvPDRxTZxft5YbXVYGgrByRJ73Cl__SmgI45UQL_9rwK_IfXzs93Fek81ucR3fgGfT1Vt5R2ArT9obqYny-A
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Arachidonic+acid+metabolism+as+a+therapeutic+target+in+AKI-to-CKD+transition&rft.jtitle=Frontiers+in+pharmacology&rft.au=Li%2C+Xiao-Jun&rft.au=Suo%2C+Ping&rft.au=Wang%2C+Yan-Ni&rft.au=Zou%2C+Liang&rft.date=2024&rft.issn=1663-9812&rft.eissn=1663-9812&rft.volume=15&rft_id=info:doi/10.3389%2Ffphar.2024.1365802&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fphar_2024_1365802
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon